Kevin Denny, MBA, DABT

Executive Technical Director, Laboratory Testing Division

WuXi AppTec

Kevin Denny, MBA, DABT, is an Executive Technical Director at WuXi AppTec’s Laboratory Testing Division and a board-certified toxicologist. He leads non-clinical and regulatory strategy for IND-enabling programs through late-stage submissions, with deep experience in GLP toxicology, global regulatory pathways, and cross-functional program leadership.

The Importance of a Hybrid Testing Approach for Safety Assessments in the NAM-Enabled Era
Thursday, October 29, 2026
For decades, in vivo models have been the standard in preclinical testing before a drug moves to first-in-human (FIH) trials. But a recent evolution in regulatory expectations has accelerated a steady shift away from in vivo testing, in favor of New ...